Literature DB >> 17950542

Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization.

S A Heldt1, K J Ressler.   

Abstract

In the adult brain, GABA is the major inhibitory neurotransmitter. Understanding of the behavioral and pharmacological functions of GABA has been advanced by recent studies of mouse lines that possess mutations in various GABA receptor subtypes and associated proteins. Genetically altered mice have become important tools for discerning GABAergic function. Thus detailed knowledge of the anatomical distribution of different GABA(A) subtype receptors in mice is a prerequisite for understanding the neural circuitry underlying changes in normal and drug-induced behaviors seen in mutated mice. In the current study, we used in situ hybridization histochemistry with [(35)S]UTP-labeled riboprobes to examine the regional expression pattern of mRNA transcripts for seven major GABA(A) receptor subunits in adjacent coronal brain sections (alpha 1, alpha 2, alpha 3, alpha 5, beta 2, beta 3, and gamma 2). Our results indicate that many of these GABAergic genes are co-expressed in much of the adult brain including the neocortex, hippocampus, amygdala, thalamus and striatum. However, each gene also shows a unique region-specific distribution pattern, indicative of distinct neuronal circuits that may serve specific physiological and pharmacological functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950542      PMCID: PMC2292345          DOI: 10.1016/j.neuroscience.2007.09.008

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  62 in total

1.  Differential expression of GABA(A) receptor subunits in the distinct nuclei of the rat amygdala.

Authors:  Juri Fujimura; Masatoshi Nagano; Hidenori Suzuki
Journal:  Brain Res Mol Brain Res       Date:  2005-04-19

2.  GABA(A) receptor changes in acute allopregnanolone tolerance.

Authors:  Vita Birzniece; Sahruh Türkmen; Charlotte Lindblad; Di Zhu; Inga-Maj Johansson; Torbjörn Bäckström; Göran Wahlström
Journal:  Eur J Pharmacol       Date:  2006-03-02       Impact factor: 4.432

3.  Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification.

Authors:  K H Backus; M Arigoni; U Drescher; L Scheurer; P Malherbe; H Möhler; J A Benson
Journal:  Neuroreport       Date:  1993-12-13       Impact factor: 1.837

4.  Expression of gamma-aminobutyric acid A receptor subunits alpha1, beta1, gamma2 mRNA in rats with hepatic encephalopathy.

Authors:  Xiao-Qing Li; Lei Dong; Zhong-Hua Liu; Jin-Yan Luo
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

5.  Age-related changes in GABA(A) receptor subunit composition and function in rat auditory system.

Authors:  D M Caspary; T M Holder; L F Hughes; J C Milbrandt; R M McKernan; D K Naritoku
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  Deafness-related plasticity in the inferior colliculus: gene expression profiling following removal of peripheral activity.

Authors:  Avril Genene Holt; Mikiya Asako; Catherine A Lomax; James W MacDonald; Ling Tong; Margaret I Lomax; Richard A Altschuler
Journal:  J Neurochem       Date:  2005-06       Impact factor: 5.372

7.  Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.

Authors:  Rosa L Fradley; Martin R Guscott; Sharlene Bull; David J Hallett; Simon C Goodacre; Keith A Wafford; Elizabeth M Garrett; Richard J Newman; Gillian F O'Meara; Paul J Whiting; Thomas W Rosahl; Gerard R Dawson; David S Reynolds; John R Atack
Journal:  J Psychopharmacol       Date:  2006-11-08       Impact factor: 4.153

8.  Immunohistochemical and neurochemical evidence for GABAA receptor heterogeneity between the hypothalamus and cortex.

Authors:  J R Inglefield; W Sieghart; C K Kellogg
Journal:  J Chem Neuroanat       Date:  1994-10       Impact factor: 3.052

9.  Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain.

Authors:  G E Duncan; G R Breese; H E Criswell; T J McCown; J S Herbert; L L Devaud; A L Morrow
Journal:  Neuroscience       Date:  1995-02       Impact factor: 3.590

10.  gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit.

Authors:  K Quirk; N P Gillard; C I Ragan; P J Whiting; R M McKernan
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

View more
  28 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

2.  A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.

Authors:  Kathryn M Gill; Daniel J Lodge; James M Cook; Shamim Aras; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2011-05-11       Impact factor: 7.853

3.  Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes.

Authors:  K L Eagleson; M C Gravielle; L J Schlueter McFadyen-Ketchum; S J Russek; D H Farb; P Levitt
Journal:  Neuroscience       Date:  2010-04-07       Impact factor: 3.590

4.  Localization of brain 5α-reductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity.

Authors:  Charles E Roselli; Timothy J Finn; Sean M Ronnekleiv-Kelly; Michelle A Tanchuck; Katherine R Kaufman; Deborah A Finn
Journal:  Alcohol       Date:  2011-09-14       Impact factor: 2.405

5.  The hypnotic zolpidem increases the synchrony of BOLD signal fluctuations in widespread brain networks during a resting paradigm.

Authors:  Stephanie C Licata; Lisa D Nickerson; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Neuroimage       Date:  2013-01-05       Impact factor: 6.556

Review 6.  Identification and characterization of anesthetic targets by mouse molecular genetics approaches.

Authors:  Berthold Drexler; Bernd Antkowiak; Elif Engin; Uwe Rudolph
Journal:  Can J Anaesth       Date:  2010-12-21       Impact factor: 5.063

7.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

8.  Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.

Authors:  Georgette M Gafford; Ji-Dong Guo; Elizabeth I Flandreau; Rimi Hazra; Donald G Rainnie; Kerry J Ressler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-19       Impact factor: 11.205

Review 9.  Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia.

Authors:  Anthony A Grace
Journal:  Neuropharmacology       Date:  2011-05-23       Impact factor: 5.250

10.  Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

Authors:  Kathryn M Gill; James M Cook; Michael M Poe; Anthony A Grace
Journal:  Schizophr Bull       Date:  2014-01-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.